358 related articles for article (PubMed ID: 11398149)
1. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
[TBL] [Abstract][Full Text] [Related]
2. Effect of probucol on blood cholesterol and basal and lovastatin-induced 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in mice.
Gebhard RL; Prigge WF; Andreini JP; Freeman ML
J Lab Clin Med; 1991 Apr; 117(4):299-304. PubMed ID: 2010669
[TBL] [Abstract][Full Text] [Related]
3. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
Hall IH; Wong OT; Simlot R; Izydore RA
Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.
Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y
J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232
[TBL] [Abstract][Full Text] [Related]
5. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.
Beisiegel U; Weber W; Ihrke G; Herz J; Stanley KK
Nature; 1989 Sep; 341(6238):162-4. PubMed ID: 2779654
[TBL] [Abstract][Full Text] [Related]
6. Effects of probucol on low-density lipoprotein catabolism in guinea pigs.
Hidaka K; Takada Y; Matsunaga A; Sasaki J; Arakawa K
Artery; 1992; 19(3):162-76. PubMed ID: 1637257
[TBL] [Abstract][Full Text] [Related]
7. [Effect of pravastatin on hepatic cholesterol metabolism].
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
Fortschr Med; 1991 Mar; 109(8):189-94. PubMed ID: 1905265
[TBL] [Abstract][Full Text] [Related]
8. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
9. Mode of hypocholesterolemic action of probucol in animals and man.
Beynen AC
Artery; 1987; 14(2):113-26. PubMed ID: 3551883
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of action of hypolipemic drugs].
Fruchart JC
J Pharm Belg; 1992; 47(4):345-50. PubMed ID: 1403601
[TBL] [Abstract][Full Text] [Related]
11. Receptor interactions controlling lipoprotein metabolism.
Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
Can J Biochem Cell Biol; 1985 Aug; 63(8):898-905. PubMed ID: 2998579
[TBL] [Abstract][Full Text] [Related]
12. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
Ide H; Fujiya S; Aanuma Y; Agishi Y
Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
[TBL] [Abstract][Full Text] [Related]
13. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in mouse peritoneal macrophages.
Angelin B
Biochem J; 1988 Oct; 255(2):529-34. PubMed ID: 3202831
[TBL] [Abstract][Full Text] [Related]
14. Regulation of lymphocyte proliferation by cholesterol: the role of endogenous sterol metabolism and low density lipoprotein receptors.
Cuthbert JA; Lipsky PE
Int J Tissue React; 1987; 9(6):447-57. PubMed ID: 3448024
[TBL] [Abstract][Full Text] [Related]
15. Identification of low density lipoprotein receptor abnormalities by assaying functional receptors on proliferating lymphocytes.
Cuthbert JA; Lipsky PE
Arteriosclerosis; 1989; 9(1 Suppl):I43-9. PubMed ID: 2912432
[TBL] [Abstract][Full Text] [Related]
16. [Regulation of blood cholesterol, mechanism of hypercholesterolemia].
Luc G; Douste-Blazy P; Fruchart JC
Rev Prat; 1989 Apr; 39(12):1019-22. PubMed ID: 2740766
[TBL] [Abstract][Full Text] [Related]
17. Effect of a new synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on cholesterol synthesis and low density lipoprotein uptake by primary cultures of rat hepatocytes.
Saito Y; Shiki Y; Shirai K; Yoshida S
Arzneimittelforschung; 1988 Feb; 38(2):251-3. PubMed ID: 3130840
[TBL] [Abstract][Full Text] [Related]
18. Complete protein sequence and identification of structural domains of human apolipoprotein B.
Knott TJ; Pease RJ; Powell LM; Wallis SC; Rall SC; Innerarity TL; Blackhart B; Taylor WH; Marcel Y; Milne R
Nature; 1986 Oct 23-29; 323(6090):734-8. PubMed ID: 3773997
[TBL] [Abstract][Full Text] [Related]
19. The effects of probucol on lipoprotein metabolism in the rat.
Staels B; van Tol A; Jansen H; Auwerx J
Biochim Biophys Acta; 1991 Aug; 1085(1):131-5. PubMed ID: 1892873
[TBL] [Abstract][Full Text] [Related]
20. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Grundy SM; Mok HY
J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
